English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Mailing Address: Viviane flumignan zetola • Rua General Carneiro, 181 – sala 1236 – 80060-900 – Curitiba, PR E-mail: viviane@flumignano.com Manuscript received March 5, 2006; revised manuscript received April 13, 2006; accepted May 9, 2006. The first clinical trials on the utility of Transcranial Doppler (TCD) in acute ischemic stroke (AIS) were conducted still in the pre-thrombolysis stage. Middle cerebral artery (MCA) mean flow velocity (MV) below 20 cm/sec or 50% below contralateral MCA within 24 hours translates worse prognostics factors1. Intravenous thrombolysis in the management of AIS brought forth an even higher utility of TCD in the acute phase – to add to emergency evaluation – thus allowing the identification of intracranial occlusion and acting as a unique tool for continuous monitoring of vessel recanalization2. More recent study designs suggest that changes found in TCD should be added to inclusion criteria for the use of intravenous thrombolytic, since that therapeutic regimen is potentially indicated and beneficial in cases of encephalic ischemia with intracranial artery branch occlusion3-5.

Uso do doppler transcraniano na fase aguda do acidente vascular cerebral isquêmico